In silico discovery of novel Retinoic Acid Receptor agonist structures
BACKGROUND: Several Retinoic Acid Receptors (RAR) agonists have therapeutic activity against a variety of cancer types; however, unacceptable toxicity profiles have hindered the development of drugs. RAR agonists presenting novel structural and chemical features could therefore open new avenues for...
Bewaard in:
| Gepubliceerd in: | BMC Struct Biol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2001
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC32304/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11405897/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1472-6807-1-1 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|